Skip to content
HelixPeptide Health

Peptide formulary

MOTS-c

MOTS-c is a small peptide encoded within mitochondrial DNA and produced by the body. Dr. Luria may prescribe it within protocols focused on metabolic health, energy, and healthy aging.

A mitochondrial-derived peptide studied for its role in metabolic regulation and cellular energy.

Class

Mitochondrial-derived peptide (16 amino acids)

Administration

Subcutaneous injection; often intermittent dosing

Typical goals

Metabolic health, energy, performance and healthy aging

What it is

MOTS-c, in plain language.

MOTS-c is a naturally occurring peptide encoded not in the cell's main genome but within mitochondrial DNA, the energy-producing compartments of your cells. The compounded form Dr. Luria prescribes mirrors that sequence.

It is most often discussed in the context of metabolism and energy, and is a subject of interest in healthy-aging conversations. Dr. Luria frames it as one possible element of a broader, measured plan.

As with other newer peptides, the human evidence base is still developing, and Dr. Luria reviews it with you honestly.

Mechanism

How mots-c works in the body.

MOTS-c is studied for its influence on cellular energy metabolism, including the AMPK pathway, a central regulator of how cells sense and use energy.

It is also studied for effects on insulin sensitivity and the way the body responds to exercise, which is why it appears in metabolic and performance discussions.

The mechanism is an area of active research rather than settled clinical fact. Dr. Luria measures relevant markers where appropriate and monitors response over time.

Who it's typically for

The patient profile.

MOTS-c is most often considered for adults pursuing metabolic health, steady energy, and healthy-aging goals, typically alongside training, nutrition, and baseline labs Dr. Luria reviews.

It works as part of a plan, not in place of foundational health. Dr. Luria evaluates whether it is appropriate for you.

What patients commonly report

Reported experiences.

Energy

Patients have reported a steadier sense of day-to-day energy; individual and variable.

Metabolic markers

Some patients track changes alongside their own labs over a multi-month protocol.

Exercise capacity

Some describe training feeling more productive; develops gradually.

Vitality

Many report a general sense of resilience over time.

Individual response varies. The human evidence base is developing, not every patient experiences every benefit, and timelines differ.

Common questions

MOTS-c, answered.

What makes MOTS-c different from other peptides?
MOTS-c is a mitochondrial-derived peptide, meaning it is encoded within mitochondrial DNA and is studied for effects on cellular energy metabolism. Dr. Luria explains where it fits relative to other options.
Is it FDA-approved?
No. MOTS-c is a compounded preparation, not an FDA-approved finished drug product. Dr. Luria reviews its current regulatory standing with you.
Do I need lab work?
For metabolic goals, Dr. Luria often reviews baseline labs before prescribing and may track relevant markers over time.

Considerations

When mots-c may not be appropriate.

MOTS-c is generally not appropriate during pregnancy or breastfeeding, with active malignancy, or alongside certain medical conditions, and its long-term human safety data are limited. Full evaluation happens in consultation before any protocol is set.

Begin

Is mots-c right for you?

Book a consultation with Dr. Luria to discuss your goals and whether mots-c or a different protocol fits your clinical picture.

This article is educational and does not constitute medical advice. Decisions about peptide therapy should be made in consultation with a licensed physician who has reviewed your individual health history. MOTS-c is a compounded prescription prepared by Blue Atlas Pharmacy, a licensed 503A compounding pharmacy, under the prescription of Dr. Jamie Luria. Compounded medications are not FDA-approved for safety, efficacy, or quality.